Ailan Guo
0000-0002-4309-2481
Publication & Citation Trends
Most Cited Works
Publications
75 total
Abstract 1370: ADME and toxicology profiles of first-in-class DRD2/ClpP-targeted imipridone ONC201
Cited by 4
Semantic Scholar
EXTH-77. ONC201 EXHIBITS PASSIVE DIFFUSION AND BROAD DISTRIBUTION IN THE CENTRAL NERVOUS SYSTEM OA
Cited by 0
Semantic Scholar
EXTH-70. CYP450 AND METABOLIC PROFILING OF ANTI-CANCER IMIPRIDONE ONC201 OA
Cited by 0
Semantic Scholar
Phosphoprotein-based biomarkers as predictors for cancer therapy OA
Cited by 28
Semantic Scholar
Identification of Rpl29 as a major substrate of the lysine methyltransferase Set7/9 OA
Cited by 25
Semantic Scholar
Akt methylation by SETDB1 promotes Akt kinase activity and oncogenic functions OA
Cited by 125
Semantic Scholar
The SCFβ-TRCP E3 ubiquitin ligase complex targets Lipin1 for ubiquitination and degradation to promote hepatic lipogenesis OA
Cited by 55
Semantic Scholar
Multiplexed Phosphoproteomic Profiling Using Titanium Dioxide and Immunoaffinity Enrichments Reveals Complementary Phosphorylation Events. OA
Cited by 53
Semantic Scholar
Research Topics
Cancer-related gene regulation
(11)
Epigenetics and DNA Methylation
(9)
Drug Transport and Resistance Mechanisms
(9)
Plant-Microbe Interactions and Immunity
(8)
PI3K/AKT/mTOR signaling in cancer
(7)
Frequent Co-Authors
Affiliations
Rutgers, The State University of New Jersey
AstraZeneca (United Kingdom)
Roche (Switzerland)
University of Maryland, Baltimore
Merck & Co., Inc., Rahway, NJ, USA (United States)